2Dunn CJ,Plosker GL, Keating GM, et al. Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs, 2003,63: 1743 ～1748.
4Rosenstock J , Dailey G, Massi - Benedetti M, et al, Reduced hypoglycemia risk with insulin glargine: a meta - analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care, 2005, 28:950 ～ 955.
二级参考文献8
1Riddle MC,Rosenstock J,Gerich J.Insulin Glargine 4002 Study Investigators.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003; 26(11):3 080-3 086.
2HOE 901/3002 Study Group.Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes[J].Diabetes Care,2000; 23(8):1 130-1 136
3UKPDS Study Group.Stratton IM,Adler AI,Neil HAW,Matthews DR,Manley SE,Cull CA,Hadden D,Turner RC,Holman RR.Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes:prospective observational study (UKPDS 35) [J].BMJ,20
4Wright A,Burden ACF,Paisey RB.Sulfonylurea Inadequacy:Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)[J].Diabetes Care,2002; 25(2):330-336
5Turner RC,Cull CA,Frighi V,Holman RR.Glycemic control with diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus:progressive requirement for multiple therapies (UKPDS 49).UK Prospective Diabetes Study (UKPDS) Group[J].JAMA,1999;
6UKPDS Study Group.Klein R,Klein BE,Moss SE.Relation of glycemic control to diabetic microvascular complications indiabetes mellitus[J].Ann Intern Med,1996;124(1 Pt 2):90-96
7UKPDS Study Group.Overview of six years' therapy of type 2 diabetes-a progressive disease (UKPDS 16)[J].Diabetes Care,1995; 44(11):1 249-1 258
9American Diabetes Association. Report of the expertcommittee on the diagnosis and classification of diabetesmellitus. Diabetes Care 1997 ;20:1183.
10Wright A, Burden AC, Paisey RB, et al. Sulforrylurea inadequacy efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U. K. Prospective Study[J]. Diabetes Care, 2002, 25(2) :330-336.
